LMVRX
Price
$120.47
Change
+$0.34 (+0.28%)
Updated
Jan 17 closing price
Net Assets
4B
RMFCX
Price
$55.77
Change
+$0.30 (+0.54%)
Updated
Jan 17 closing price
Net Assets
103.41B
Ad is loading...

LMVRX vs RMFCX

Header iconLMVRX vs RMFCX Comparison
Open Charts LMVRX vs RMFCXBanner chart's image
ClearBridge Value R
Price$120.47
Change+$0.34 (+0.28%)
VolumeN/A
Net Assets4B
American Funds American Mutual R3
Price$55.77
Change+$0.30 (+0.54%)
VolumeN/A
Net Assets103.41B
LMVRX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LMVRX vs. RMFCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMVRX is a Buy and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 103B vs. LMVRX (4B). RMFCX pays higher dividends than LMVRX: RMFCX (1.69) vs LMVRX (0.39). LMVRX was incepted earlier than RMFCX: LMVRX (18 years) vs RMFCX (23 years). LMVRX is a more actively managed with annual turnover of: 60.00 vs. RMFCX (25.00). LMVRX has a lower initial minimum investment than RMFCX: LMVRX (0) vs RMFCX (250). LMVRX (12.92) and RMFCX (12.43) have marching annual gain over last year. RMFCX return over 5 years is better than : 37.82 vs. LMVRX (21.16).
LMVRXRMFCXLMVRX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years23 years-
Gain YTD3.7552.162174%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets4B103B4%
Annual Yield % from dividends0.391.6923%
Returns for 1 year12.9212.43104%
Returns for 3 years3.7712.6030%
Returns for 5 years21.1637.8256%
Returns for 10 years69.7365.18107%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDZI5.160.23
+4.77%
CADIZ
HOOD48.152.07
+4.49%
Robinhood Markets
NERV2.230.08
+3.72%
Minerva Neurosciences
WHD63.63-0.15
-0.24%
Cactus
EOLS10.51-0.10
-0.94%
Evolus